BETAMETHASONE DIPROPIONATE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 226 adverse event reports in the FDA FAERS database where BETAMETHASONE DIPROPIONATE was used for Psoriasis.
Most Reported Side Effects for BETAMETHASONE DIPROPIONATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 1,034 | 40.7% | 41 | 198 |
| Macular degeneration | 522 | 20.5% | 0 | 122 |
| Off label use | 330 | 13.0% | 99 | 201 |
| Condition aggravated | 280 | 11.0% | 132 | 166 |
| Therapeutic product effect incomplete | 251 | 9.9% | 45 | 184 |
| Product use in unapproved indication | 230 | 9.1% | 59 | 67 |
| Pain in extremity | 229 | 9.0% | 44 | 90 |
| Nausea | 200 | 7.9% | 71 | 164 |
| Pain | 192 | 7.6% | 21 | 127 |
| Dyspnoea | 173 | 6.8% | 93 | 139 |
| Erythema | 156 | 6.1% | 0 | 85 |
| Pneumonia | 155 | 6.1% | 24 | 43 |
| Abdominal pain | 152 | 6.0% | 68 | 140 |
| Constipation | 143 | 5.6% | 62 | 132 |
| Pyrexia | 142 | 5.6% | 22 | 134 |
Other Indications for BETAMETHASONE DIPROPIONATE
Product used for unknown indication (1,125)
Eczema (97)
Swelling (88)
Dermatitis atopic (62)
Rash (54)
Gingivitis (45)
Pruritus (42)
Maternal therapy to enhance foetal lung maturity (39)
Dermatitis (25)
Off label use (20)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)